Literature DB >> 21864073

Reversible cerebral vasoconstriction syndrome: current and future perspectives.

Shih-Pin Chen1, Jong-Ling Fuh, Shuu-Jiun Wang.   

Abstract

Reversible cerebral vasoconstriction syndromes (RCVS) are characterized by recurrent acute severe headaches, namely thunderclap headaches, and multifocal segmental vasoconstrictions. Interest has arisen in the definitions, clinical presentations, differential diagnoses, risk factors and complications of RCVS. This article will comprehensively review the milestone monographs and the latest research work addressing these issues. Studies that have focused on the relationship between RCVS and thunderclap headache will be detailed. We will also discuss research on the enigmatic pathophysiology and potential therapeutic approaches. Up-to-date information and challenges, undergoing studies and future research directions will be deeply probed.

Entities:  

Mesh:

Year:  2011        PMID: 21864073     DOI: 10.1586/ern.11.112

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  29 in total

1.  Thunderclap headache as the main symptom of an acute aortic dissection type A.

Authors:  H Rust; H Kimmig
Journal:  J Neurol       Date:  2013-05-28       Impact factor: 4.849

Review 2.  Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.

Authors:  Sarthak Gupta; Robert Zivadinov; Deepa Ramasamy; Julian L Ambrus
Journal:  Clin Rheumatol       Date:  2013-11-26       Impact factor: 2.980

Review 3.  Reversible cerebral vasoconstriction syndrome: updates and new perspectives.

Authors:  Huma U Sheikh; Paul G Mathew
Journal:  Curr Pain Headache Rep       Date:  2014-05

4.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

Review 5.  Thunderclap headache.

Authors:  Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

6.  Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure.

Authors:  Mehmet A Topcuoglu; Ruchira M Jha; Jacob George; Matthew P Frosch; Aneesh B Singhal
Journal:  Neurol Clin Pract       Date:  2017-02

Review 7.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

Review 8.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

9.  Dynamic Changes in White Matter Hyperintensities in Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Shih-Pin Chen; Kun-Hsien Chou; Jong-Ling Fuh; Yi-Hua Huang; Chu-Chung Huang; Jiing-Feng Lirng; Yen-Feng Wang; Ching-Po Lin; Shuu-Jiun Wang
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

10.  Reversible cerebral vasoconstriction complicated with brain infarction immediately after carotid artery stenting.

Authors:  Eiji Higashi; Takeshi Uwatoko; Taichiro Mizokami; Yusuke Sakaki; Shuji Sakata; Hiroshi Sugimori
Journal:  Interv Neuroradiol       Date:  2018-07-03       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.